Close Menu
    Facebook X (Twitter) Instagram
    ScoopSquare24
    • Home
    • News
    • AI
    • Crypto
    • Finance
    • Stocks
    Facebook X (Twitter) Instagram
    ScoopSquare24
    Home»News»Stocks»Red Cat Holdings (RCAT) Stock Surges to 52-Week Peak on Explosive Revenue Forecast
    Stocks

    Red Cat Holdings (RCAT) Stock Surges to 52-Week Peak on Explosive Revenue Forecast

    Oli DaleBy Oli DaleMarch 18, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Key Takeaways

    • Red Cat shares surged approximately 12% Wednesday, approaching the 52-week peak of $18.78
    • Fourth-quarter revenue projections range from $24M to $26.5M, representing a 1,842% jump from last year’s $1.3M
    • Fiscal 2025 annual revenue outlook stands at $38M to $41M, more than doubling fiscal 2024’s $15.6M
    • The company’s U.S. Army SRR Tranche 2 agreement has grown to approximately $35M, providing solid revenue visibility
    • Wall Street consensus maintains a “Hold” stance with a mean price objective of $19.33

    Red Cat Holdings has delivered an impressive performance throughout the year, with Wednesday’s session proving particularly eventful. Shares rallied roughly 12% during trading hours, reaching the $18.10 to $18.13 territory, as market participants braced for the company’s fourth-quarter financial results scheduled for after-market release.


    RCAT Stock Card
    Red Cat Holdings, Inc., RCAT

    The enthusiasm stems from compelling financial projections. In January, Red Cat announced preliminary fourth-quarter revenue expectations between $24M and $26.5M. Analyst consensus entering the report stood at approximately $23.95M, indicating the company’s own projections exceeded Street estimates.

    To put this in perspective, the same quarter last year generated merely $1.3M in revenue. The year-over-year expansion rate of 1,842% is genuinely exceptional.

    For the complete fiscal year 2025, revenue is projected to reach $38M to $41M—a significant jump from fiscal 2024’s $15.6M, and surpassing the guidance range management provided in November.

    Key Growth Catalysts

    The primary catalyst fueling this expansion has been the U.S. Army’s Short Range Reconnaissance (SRR) Tranche 2 procurement agreement. Initially secured as a Limited Rate Production arrangement in July 2025, the contract value has expanded to roughly $35M. The agreement focuses on Red Cat’s Teal drone technology.

    The third quarter already demonstrated this upward trajectory. That period delivered $9.6M in revenue—a 646% year-over-year increase and 200% sequential gain—surpassing analyst projections. Following that performance, management elevated its Q4 outlook, with CEO Jeff Thompson stating Q4 would generate “more revenue in one quarter than we have ever done in a 12 month period.”

    Thompson also identified the Black Widow drone platform as the current leading revenue generator. The system recently gained approval for the NATO NSPA catalog, which facilitates procurement access across NATO member states and allied nations.

    The organization has also been diversifying beyond terrestrial drone systems. It introduced Blue Ops, a maritime-focused division, which Thompson characterized as “perhaps the most exciting strategic expansion.”

    Market Sentiment and Institutional Activity

    Ladenburg Thalmann elevated its price objective on RCAT from $15 to $20 in a March 3 analysis, maintaining a “Buy” recommendation. Needham kept its “Buy” rating with a $16 target as of March 2. Northland Securities holds a $22 price objective established in January, while Weiss Ratings maintains a “Sell” position.

    Overall Wall Street consensus remains at “Hold” with an average price target of $19.33.

    Regarding institutional activity, multiple investment firms expanded their holdings during Q4 2024. Invesco boosted its position by 36.3%, Janus Henderson increased by 29.5%, and Caitong International Asset Management enlarged its stake by more than 1,800%. Institutional ownership currently represents roughly 38% of shares outstanding.

    The stock’s 50-day moving average sits at $13.55 while the 200-day moving average stands at $11.00. Wednesday’s 12% advance brings RCAT close to its 52-week peak of $18.78.

    CFO Chris Ericson observed that the company’s financial metrics demonstrate enhanced operational leverage as manufacturing capacity expands to accommodate increasing order volumes.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Oli Dale
    • Website

    Related Posts

    Circle Internet (CRCL) Hit with Class Action Lawsuit Over $280M Drift Protocol Breach

    April 17, 2026

    JPMorgan Analysts Say CLARITY Act Could Pass Before Midterm Elections

    April 17, 2026

    Tom Lee Predicts Further Gains After April 2026 Market Records

    April 17, 2026
    Leave A Reply Cancel Reply

    Breaking News
    Blockonomi

    Crypto News Just Turned Bullish: Coinbase CEO Brian Armstrong Calls a $60,000 Bitcoin Bottom While DOGE Holders Move to Pepeto

    Blockonomi
    Jun 16, 2026 9:27 PM
    Parameter

    CervoMed (CRVO) Stock Soars 32% on $3 Million Director Purchase

    Parameter
    Jun 16, 2026 8:27 PM
    Blockonomi

    CervoMed (CRVO) Surges 32% as Director Purchases $3 Million in Shares

    Blockonomi
    Jun 16, 2026 8:24 PM
    Moneycheck

    CervoMed (CRVO) Surges 32% Following Director’s $3 Million Stock Purchase

    Moneycheck
    Jun 16, 2026 8:24 PM
    Parameter

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Assessment of mRNA Flu Vaccine

    Parameter
    Jun 16, 2026 8:20 PM
    Blockonomi

    Moderna (MRNA) Stock Surges 9% Following Positive FDA Review of mRNA Flu Vaccine

    Blockonomi
    Jun 16, 2026 8:17 PM
    Moneycheck

    Moderna (MRNA) Stock Surges 9% After FDA Gives Positive Signal on mRNA Flu Vaccine

    Moneycheck
    Jun 16, 2026 8:17 PM
    Coincentral

    CervoMed (CRVO) Stock Jumps 32% After Director Buys $3M – Time to Buy?

    Coincentral
    Jun 16, 2026 8:14 PM
    Parameter

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade from Underperform

    Parameter
    Jun 16, 2026 8:13 PM
    Blockonomi

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Blockonomi
    Jun 16, 2026 8:10 PM
    Moneycheck

    Palantir (PLTR) Stock Drops 2% Despite Wolfe Research Upgrade to Peer Perform

    Moneycheck
    Jun 16, 2026 8:10 PM
    Coincentral

    Moderna (MRNA) Stock Jumps 9% as FDA Clears Key Hurdle for mRNA Flu Shot

    Coincentral
    Jun 16, 2026 8:06 PM
    Coincentral

    Palantir (PLTR) Stock Falls 2% Even After Getting a Wall Street Upgrade

    Coincentral
    Jun 16, 2026 8:01 PM
    Blockonomi

    Anchorage Digital Unlocks New SWEEP Infrastructure for Institutions

    Blockonomi
    Jun 16, 2026 7:16 PM
    Parameter

    Alphabet (GOOG) Stock: Rises as Google Expands Android 17 Parental Controls

    Parameter
    Jun 16, 2026 7:13 PM
    Facebook X (Twitter) Instagram Pinterest
    ScoopSquare24

    Copyright © 2013 - 2026 Kooc Media Ltd. All rights reserved. Registered Company No.05695741
    Our Sites: FlowPresets / GardenBeast / GolfMonster / Blockonomi / Money Check / CoinCentral / Parameter / Circlo / Computing.net

    Type above and press Enter to search. Press Esc to cancel.